Au cours de cette étude, nous avons approfondi nos connaissances concernant l’effet des conditions de culture sur la quantité et la qualité d’une protéine recombinante produite par des cellules CHO. En particulier, nous avons étudié l’influence de 3 composés (citrate de fer, pluronic F-68 et éthanolamine) présents dans le milieu BDM mais absent du milieu RPMI avec sérum (FCS-RPMI) sur la croissance des cellules CHO, la production de l’interféron-gamma humain recombinant (IFN-γ) ainsi que sa qualité. L’ajout de pluronic F-68 (0,1%) et de citrate de fer (500 µM) dans le milieu RPMI sans sérum a permis d’obtenir une croissance cellulaire comparable à celle obtenue avec le milieu FCS-RPMI. Par ailleurs, dans ces conditions de culture, la production de l’IFN-g est également augmentée. L’ajout de citrate de fer dans le milieu FCS-RPMI permet non seulement d’améliorer la croissance des cellules CHO mais également la production de l’IFN-γ. Avec le milieu FCS-RPMI, la macrohétérogénéité de la glycosylation de l’IFN-γ change au cours du procédé discontinu, cette dernière est maintenue constante uniquement lorsque du citrate de fer est ajouté à ce même milieu de culture. En outre, des activités gélatinase et caséinase appartenant aux familles des métalloprotéases et des protéases à sérine ont été mises en évidence au cours des cultures de cellules CHO. Quel que soit le milieu utilisé (RPMI, BDM avec ou sans sérum), l’ajout de citrate de fer permet de maîtriser et d’éviter la protéolyse de l’IFN-γ. Enfin, la relation entre le degré de glycosylation macroscopique de l’IFN- γ et son activité biologique (immunomodulatrice) in-vitro a été établie / In this study, we characterized the effect of culture conditions on the quantity and the quality of a recombinant protein, IFN-γ, produced by CHO cells. In particular, we studied the effect of 3 components (iron citrate, pluronic F-68 and ethanolamine) that are present in the BDM medium, but completely lacking in RPMI serum medium (FCS-RPMI) on CHO cell growth, as well as the production and quality of recombinant IFN-γ.The addition of Pluronic F-68 (0.1%) and iron citrate (500 µM) in RPMI without serum resulted in growth kinetic performances similar to those observed in FCS-RPMI. Furthermore, in these culture conditions, IFN- γ production was improved. Addition of iron citrate in FCS-RPMI improved cell growth, as well as IFN-γ production. Whereas the glycosylation pattern of recombinant IFN-γ produced by CHO cells was not constant when the culture was performed in FCS-RPMI, the glycosylation pattern of IFN-γ remained constant when iron citrate was added in the medium. In addition, gelatinase and caseinase enzymatic activities in CHO batch cultures were detected, due most likely to enzymes of the metalloproteases and serine protease families. Despite the type of medium used (RPMI, BDM with or without serum), addition of iron citrate minimized IFN-g proteolysis. Finally, the relationship between the macroglycosylation pattern of IFN-g and its in-vitro biological (immunomodulatory) activity was demonstrated

No description available.

Osteoarthritis (OA) is a disease characterized by the progressive degradation of articular cartilage. Current strategies for the disease are mainly towards relieving symptoms. This study was aimed to investigate the therapeutic potentials of Bone Morphogenetic Protein-9 (BMP-9), Raloxifene (Ral) and Pluronic F-68 (PLF-68) with a three-dimensional in vitro OA model. Articular chondrocytes isolated from rats were cultured in growth media and embedded in agarose to obtain agarose-chondrocyte discs. Dynamic hydrostatic mechanical stress was applied to discs. The discs were incubated with Aza-C for 48 hours for OA development. After its removal, chondrocytes were treated with different doses of BMP-9, Ral and PLF-68 for 10 days. The efficacies of treatments were evaluated by measuring cell number, glycosaminoglycan and collagen amount, and mechanical properties of the v discs. Measurements of these properties were performed with MTT, quantitative colorimetric assays, histochemical staining and mechanical tests, respectively. According to comparative results with healthy groups and controls (osteoarthritic chondrocytes without any treatment), it was found that BMP-9 had negative effect on osteoarthritic chondrocytes. On the other hand, Ral showed positive results related with matrix synthesis and mechanical properties especially at 5 &amp / #956 / M dose suggesting that it holds promise for the treatment of OA. The therapeutic effect of Ral on OA was documented for the first time in literature. The potential of PLF-68 for treatment of OA was also supported by this study considering its positive effects on cell number, collagen synthesis and mechanical properties. Yet, further investigations are also suggested for conclusive results on this agent.